To join a obesity clinical trial in United States, select a recruiting trial below and check the eligibility criteria. Contact the trial's principal investigator or the listed site in United States directly. All trials listed here are sourced from ClinicalTrials.gov, the official U.S. registry of clinical studies.

What phases are obesity trials in United States?

Active obesity trials in United States span Phase 1, Phase 2, EARLY_Phase 1, Phase 2, Phase 3, Phase 1, Phase 4. Phase I trials test safety, Phase II test efficacy, and Phase III compare against standard treatments in larger patient populations.

Browse More

All United States Trials → Global obesity Trials → All Countries → All Trials →

Active Trials in United States (33)

Mechanisms of Semaglutide Therapy in Heart Failure Patients

Sex Disparities in Hypoxic Vasodilation and Impact of Obesity

Aleniglipron Phase 2 in Type 2 Diabetes Mellitus

Inflammation, Diabetes, Ethnicity and Obesity Cohort

Harnessing Macrophage Lysosomal Lipid Metabolism in Obesity (ATM)

Lifestyle Medicine: Establishing Clinical Approaches to Chronic Disease for Rural Patients

Investigating Whether Acute Elevation of Fatty Acid Levels Alters Cerebral Glucose Transport and Metabolism

Fasting Insulin and HOMA-IR by Age, Sex, Race/Ethnicity, BMI, and PCOS Diagnosis

Concentration of n-3 PUFA Monohydroxylated Derivatives in Adults With Obesity After n-3 PUFA Supplementation.

Routine Validation and Reproducibility Testing of Laboratory Measures and Research Techniques Used for Metabolism Research (VAL)

Comparison of Body Composition Changes With Weight Loss Interventions

Pilot Study of Isocaloric Time Restricted Eating on Ketone Metabolism and Immunoregulation

Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiovascular Disease and Overweight or Obesity

Maridebart Cafraglutide Versus Placebo in Adult Participants With Obstructive Sleep Apnea on Positive Airway Pressure Therapy

Physiologic Markers of Cardiometabolic Risk in People With Type 1 Diabetes

A Study of Orforglipron (LY3502970) in Participants With Obesity or Overweight and at Least One Weight-Related Comorbidity

Chronic Widespread Pain After Rapid Weight Loss in Non-Hispanic Black and Hispanic/Latino/a/x Adults

Individualized Pharmacological Approach to Obesity in Patients With Bipolar Disorder

Stepped Care for Weight Loss Maintenance

Probiotic Intervention Study

EBT Fruit and Vegetable Prescription

Improving Glycemic Control With Electrical Stimulation

Moderately Carbohydrate-restricted Diet to Treat NAFLD in Adolescents

Feasibility of Semaglutide in Advanced Lung Disease

Triage Survey for Cardiovascular, Obesity, and Related Endocrine Trial Eligibility

Inspiratory Muscle Strength Training in Adults With Obesity

GENESIS: Genotype Guided - Natriuretic Peptides - Cardiometabolic Health Study

Predictors of Behavioral Obesity Treatment Outcomes

Tai Chi as a Novel Strategy to Increase Physical Activity Among Adults Pursuing Metabolic and Bariatric Surgery

Impact of Yo-Yo Sleep on Cardiometabolic Health

Taxi ROADmAP (Realizing Optimization Around Diet And Physical Activity)

Optimization of Chrononutrition to Reduce the Risk of Disease in Shift Workers

Dietary Intervention to Improve Kidney Transplant Outcomes

Frequently Asked Questions